Snowball logo
logo
UTHR_logo

United Therapeutics Corporation

$536.12+$3.30  (0.62%)

Frequently asked questions

What sector does United Therapeutics Corporation (UTHR) operate in?

United Therapeutics Corporation belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is United Therapeutics Corporation (UTHR) current stock price?

As of the latest data, United Therapeutics Corporation stock price is $536.12, with a previous close of $532.82. United Therapeutics Corporation gained $3.30 in the last trading session, representing a 0.62% increase.

What is United Therapeutics Corporation (UTHR) current market capitalization?

United Therapeutics Corporation market cap is approximately 23.08 billion.

What is United Therapeutics Corporation (UTHR) Earnings Per Share (EPS)?

The trailing EPS is $26.32, and the forward EPS is $28.59.

What is United Therapeutics Corporation (UTHR) Price-to-Earnings (P/E) ratio?

United Therapeutics Corporation current P/E ratio is 20.37, with a forward P/E of 18.75.

What is United Therapeutics Corporation (UTHR) EBITDA?

United Therapeutics Corporation EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 462.90 million.

Does United Therapeutics Corporation (UTHR) pay dividends?

No. United Therapeutics Corporation does not pay a dividend.

How did United Therapeutics Corporation (UTHR) perform in its most recent earnings report?

In the last report (December 31, 2025), United Therapeutics Corporation posted an EPS surprise of -2.19% and a revenue surprise of -1.65%.

When is United Therapeutics Corporation (UTHR) next earnings report?

United Therapeutics Corporation is expected to release its next earnings report on March 31, 2026.

What is United Therapeutics Corporation (UTHR) beta (volatility) score?

United Therapeutics Corporation has a beta of 0.856, meaning its volatility is roughly in line with the market.